Search Results - Lambert Busque
- Showing 1 - 12 results of 12
-
1
-
2
-
3
Combined PD-L1 and TIM3 blockade improves expansion of fit human CD8+ antigen-specific T cells for adoptive immunotherapy by Shirin Lak, Valérie Janelle, Anissa Djedid, Gabrielle Boudreau, Ann Brasey, Véronique Lisi, Ali Smaani, Cédric Carli, Lambert Busque, Vincent-Philippe Lavallée, Jean-Sébastien Delisle
Published in Molecular Therapy: Methods & Clinical Development (2022-12-01)Get full text
Article -
4
Two types of human TCR differentially regulate reactivity to self and non-self antigens by Assya Trofimov, Philippe Brouillard, Jean-David Larouche, Jonathan Séguin, Jean-Philippe Laverdure, Ann Brasey, Gregory Ehx, Denis-Claude Roy, Lambert Busque, Silvy Lachance, Sébastien Lemieux, Claude Perreault
Published in iScience (2022-09-01)Get full text
Article -
5
Clinical outcomes of high-risk patients with polycythemia vera after suboptimal response to first-line therapy who switched to ruxolitinib versus nonswitchers: results from the PV-... by Steffen Koschmieder, Clemens Schulte, Eyck von der Heyde, Lambert Busque, Françoise Boyer-Perrard, Timothy Devos, Francesco Passamonti, Wendy Y. Cheng, Mu Cheng, Marja Nuortti, Volker Baum, Claire Harrison
Published in Therapeutic Advances in Hematology (2025-07-01)Get full text
Article -
6
Symptom burden in myeloproliferative neoplasms: clinical correlates, dynamics, and survival impact—a study of 784 patients from the Quebec MPN research group by Alisa Poullet, Lambert Busque, Shireen Sirhan, Robert Delage, Ghislain Cournoyer, Ines Chamakhi, Danielle Talbot, Luigina Mollica, Daniele Marceau, Vincent Ethier, Pierre Desjardins, Harold J. Olney, Michaël Harnois, Natasha Szuber
Published in Blood Cancer Journal (2025-04-01)Get full text
Article -
7
Switching TKIs during CML therapy is frequent, mostly driven by intolerance, and does not affect survival: a prospective Quebec registry study by Lambert Busque, Marc-Étienne Beaudet, Michaël Harnois, Hanane Moussa, Natasha Szuber, Luigina Mollica, Robert Delage, Harold Olney, Pierre Laneuville, Ghislain Cournoyer, Inès Chamakhi, Marc Lalancette, Danielle Talbot, Vincent Ethier, Pierre Desjardins, Sarit Assouline
Published in Blood Cancer Journal (2025-03-01)Get full text
Article -
8
Enhancing CAR-T Efficacy in Large B-Cell Lymphoma with Radiation Bridging Therapy: A Real-World Single-Center Experience by Eva Laverdure, Luigina Mollica, Imran Ahmad, Sandra Cohen, Silvy Lachance, Olivier Veilleux, Maryse Bernard, Eve-Lyne Marchand, Jean-Sébastien Delisle, Lea Bernard, Mélissa Boileau, Tony Petrella, Sarah-Jeanne Pilon, Philippe Bouchard, Denis-Claude Roy, Lambert Busque, Isabelle Fleury
Published in Current Oncology (2025-03-01)Get full text
Article -
9
PB2681: GAPS IN THE ASSESSMENT AND MONITORING OF CARDIOVASCULAR RISK AND PSYCHOLOGICAL BURDEN IN POLYCYTHEMIA VERA: LANDMARK 2.0: A WORLDWIDE HEALTH SURVEY by Claire Harrison, David Ross, Laura Fogliatto, Lynda Foltz, Lambert Busque, Zhijian Xiao, Florian Heidel, Michael Koehler, Giuseppe A. Palumbo, Massimo Breccia, Norio Komatsu, Keita Kirito, Blanca Xicoy Cirici, Joaquín Martinez-Lopez, Alicia Rovó, Cheryl Petruk, Catalin Bobirca, Laura Mirams, Abigail Mcmillan, Gavin Harper, Jean-Jacques Kiladjian
Published in HemaSphere (2023-08-01)Get full text
Article -
10
Patient and physician perceptions regarding treatment expectations and symptomatology in polycythemia vera: Insights from the Landmark 2.0 global health survey by Claire N. Harrison, David M. Ross, Laura Maria Fogliatto, Lynda Foltz, Lambert Busque, Zhijian Xiao, Florian H. Heidel, Michael Koehler, Giuseppe A. Palumbo, Massimo Breccia, Norio Komatsu, Keita Kirito, Blanca Xicoy Cirici, Joaquin Martinez‐Lopez, Alicia Rovo, Cheryl Petruk, Catalin Bobirca, Laura Mirams, Abigail McMillan, Gavin Harper, Jean‐Jacques Kiladjian
Published in HemaSphere (2025-03-01)Get full text
Article -
11
Single UM171‐Expanded Cord Blood Transplants Support Robust T‐Cell Reconstitution with Low Rates of Severe Infections by Maude Dumont‐Lagacé, Qi Li, Mégane Tanguay, Jalila Chagraoui, Tibila Kientega, Guillaume B. Cardin, Ann Brasey, Assya Trofimov, Cédric Carli, Imran Ahmad, Nadia Bambace, Léa Bernard, Thomas L. Kiss, Jean Roy, Denis‐Claude Roy, Sébastien Lemieux, Claude Perreault, Francis Rodier, Simon Frédéric Dufresne, Lambert Busque, Silvy Lachance, Guy Sauvageau, Sandra Cohen, Jean‐Sébastien Delisle
Published in Stem Cells Translational Medicine (2020-09-01)Get full text
Article -
12
P735: EFFICACY AND SAFETY OF ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN THE CMML SUBPOPULATION FROM PHASE 2 AND ASCERTAIN PHASE 3 STUDIES by Michael Robert Savona, James K Mccloskey, Elizabeth A. Griffiths, Karen Yee, Amer M. Zeidan, Aref Al-Kali, H. Joachim Deeg, Prapti A. Patel, Mitchell Sabloff, Mary-Margaret Keating, Nancy Y Zhu, Nashat Gabrail, Salman Fazal, Joseph J. Maly, Olatoyosi Odenike, Hagop Kantarjian, Amy Dezern, Casey L Oconnell, Gail Roboz, Lambert Busque, Rena Buckstein, Harshad Amin, Jasleen K Randhawa, Brian Leber, Kim-Hien Dao, Winny Chan, Aram Oganesian, Yuri Sano, Beloo Mirakhur, Harold Keer, Guillermo Garcia-Manero
Published in HemaSphere (2023-08-01)Get full text
Article
